marijuana stocks

Insys Therapeutics misses 2Q profit forecasts

Insys Therapeutics posts 2Q profit of $7.3 million, result misses forecasts

 CHANDLER, Ariz. (AP) _ Insys Therapeutics Inc. (INSY) on Thursday reported second-quarter net income of $7.3 million.

The Chandler, Arizona-based company said it had net income of 10 cents per share. Earnings, adjusted for stock option expense and pretax expenses, came to 21 cents per share.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 23 cents per share.

The specialty pharmaceutical company posted revenue of $77.6 million in the period.

Insys Therapeutics shares have more than doubled since the beginning of the year. The stock has more than tripled in the last 12 months.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

HEXO Corp (HEXO) Announces Appointment of John K. Bell as Chair of Board of Directors

HEXO Announces Appointment of John K. Bell as Chair of Board of…

AbbVie Inc. (ABBV) Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio

AbbVie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio AbbVie (NYSE: ABBV) today announced…

MariMed Inc. (MRMD) Receives Maryland State Approval for Transfer of Ownership of Kind Therapeutics USA

MariMed Receives Maryland State Approval for Transfer of Ownership of Kind Therapeutics…

$GWPH to Present at the Bank of America Merrill Lynch 2016

GW Pharmaceuticals to Present at the Bank of America Merrill Lynch 2016…